medigraphic.com

2001, Número 5

<< Anterior Siguiente >>

Rev Fac Med UNAM 2001; 44 (5)


Síndrome hepatopulmonar

Carrillo ER, González SJA,Serralde ZA

Idioma: Español
Referencias bibliográficas: 54
Paginas: 207-211
Archivo PDF: 42.93 Kb.


FRAGMENTO

Fluckieger en 1884 fue el primero en describir la asociación entre daño hepático y alteraciones en la función pulmonar al describir un caso caracterizado por cianosis, dedos en palillo de tambor y cirrosis hepática. El término de síndrome hepatopulmonar (SHP), fue acuñado en 1977 por Kennedy y Knudson.1
El SHP puede presentarse hasta en el 30% de los pacientes con daño hepático de diferente etiología y se caracteriza por la tríada de, 1. enfermedad hepática, 2. hipoxemia al aire ambiente, 3. presencia de dilataciones vasculares intrapulmonares. 2,3


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977; 72: 305-09.

  2. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Chest 1990; 98: 1053-1054.

  3. Krowka MJ, Cortese DA. Hepatopulmonary síndrome: Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105: 1528-1537.

  4. Lange P, Stoller J. The Hepatopulmonary Syndrome. Ann Intern Med. 1995; 122: 521-529.

  5. Agusti AGN, Roca J. Bosch j, Rodriguez-Roisin R. The lung in patients with cirrhosis J Hepatol 1990; 10: 251-57.

  6. Castro Mario MD, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of Liver disease. Clinics in Chest Medicine 1996; (17) 1, March 35-48.

  7. Naeije R, Melot C, Hallermans R, Mols P, Lejeune P. Pulmonary hemodynamics in liver cirrhosis. Seminars in Respiratory Medicine. 1985; 7: 164-170.

  8. Andrivet P, Cadranel J, Housset B, Herigault R, Harf A, Adnot S. Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest. 1993; 103: 500-7.

  9. Rodriguez-Roisin R. The hepatopulmary sindrome: new name, old complexities. Thorax. 1992; 47: 897-902.

  10. Rodriguez-Roisin R, Agusti AG, Roca J. Pulmonary function and liver disease. Current Opinion in Gastroenterology. 1988; 4: 609-14.

  11. Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular lung shunts. N Engl J med 1976; 274: 941-43.

  12. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: Clinical observations in 57 patients. (Abstr) Hepatology 1992; 14: 83ª.

  13. Wolfe JD, Tashkin DP, Holy Fe et al. Hypoxemia of cirrhosis: Detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med 1977 63: 746-754.

  14. Altman M, Robin ED. Platypnea (diffuse zone I phenomenon?). N Eng J med. 1969; 281: 1347-8.

  15. Robin ED, Horn B, Goris ML, Theodore J, Kessel AV, Mazoub J et al. Detection, quantitation and pathophysiology of lung spiders. Trans Assoc Am Physicians. 1975; 88: 202-16.

  16. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am. Rev Respir dis. 1989; 140: 1631-5.

  17. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-7S.

  18. Liu HJ. Cardiopulmonary dysfunction in cirrhosis. J. Gastroenterol Hepatol-1990 Jun; 14(6): 600-8.

  19. Rodríguez-Roisin R. Hepatopulmonary syndrome: the paradigm of liver-induced hypoxaemia. Clin Gastroenterol 1977 Jun; 11 (2): 387-406.

  20. Meinemann HO, Emirgil C, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J med 1960: 2S: 239-46.

  21. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am Rev Respir Dis 1989; 140: 1634-35.

  22. Daoud F, Reeves J, Schaefer JW. Failure of hypoxic pulmonary vasoconstriction in patients in with liver cirrhosis. J clin Invest 1972; 51: 1076-1080.

  23. Nakos G, Evrenglou D, Vassilakis N et al. Haemodynamics and gas exchange in liver cirrhosis: The effect of orally administered almitrine bismesylate. Respir Med 1993; 87.93-98.

  24. Genovesi M, Tierney D, Taplin G et al. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Am Rev Resp Dis 1976; 114: 59-65.

  25. Hopkins WE, Waggoner BA, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992; 70: 516-519.

  26. Hourani J, Bellamy P, Tashkin D et al. Pulmonary dysfunction in advanced liver diseases: Frequent occurrence of an abnormal diffusion capacity. Am J Med 1991; 90: 693-700.

  27. Krowka MJ, Cortese DA. Severe hypoxemia associated with liver disease:mayo Clinic experience and the experimental use of almitrine bisemesylate. Mayo clin Proc 1987; 62: 164-173.

  28. Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med. 1991; 90: 693-700.

  29. Yao EH, Kong BC, Hsue GL, Zhou AC, Wang H. Pulmonary function changes in cirrhosis of the liver. Am J Gastroenterol. 1987; 82: 352-4.

  30. Stanley NN, Woodgate DJ. Mottled chest radiograph and gas transfer defect in chronic liver disease. Thorax. 1972; 27: 315-23.

  31. Vedrinne JM, Duperret S, Bizollon T. Comparison of Transesophageal and Transthoracic Contrast Echocardiography for Detection of an Intrapulmonary shunt in Liver Disease. Chest 1997; 111: 1236-40.

  32. Krowka MJ, Tahik AHJ, Dickson ER. Intrapulmonary vascular dilatations (intrapulmonary vascular dilatations) in liver transplant candidates: Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 1165-1170.

  33. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right to left shunting in end stage hepatic disease. Am J Cardiol 1992; 70: 516-19.

  34. Nemec JJ, Davison MB, Marwick TH, Chimowitz MI, Stoller JK, Klein AL. Detection and evaluation of intrapulmonary vascular shunt with contrast Doppler transesophageal echocardiography. J Am Soc Echocardiogr. 1991; 4: 79-83.

  35. Gates GF, Orme HW, Dore EK. Cardiac shunt assessment in children with macroaggregated albumin technetium-99m. Radiology.1974; 112: 649-53.

  36. Genovesi MG, Tierney DF, Taplan GV, Eisenberg H. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels: Limitation of conventional techniques. Am Rev Respir dis 1976; 114: 59-65.

  37. Robin ED, Horn B, Goris ML. Detection, quantitation and pathophysiology of lung spiders. Clin Res 1975; 23: 448.

  38. Naeije R, Melot C, Hallemans R. Haemodynamics and gas exchange in liver cirrhosis: The effect of orally administered alimitrine bismesylate. Respir Med 1993; 87: 93-98.

  39. Keren G, Boichis H Zwas TS, Frand M. Pulmonary arteriovenous fistulas in hepatic cirrhosis. Arch Dis Child 1983; 58: 302-304.

  40. Williams A, Treswby P Williams R, Reid L. Structural alterations to the pulmonary circulation in fulminant hepatic failure. Thorax 1979; 34: 447-453.

  41. Jones FD, Kuo PC, Johnson LB. The coexistence of Portopulmonary Hypertension and Hepatopulmonary Syndrome. 1999; 90: 626-30.

  42. Hansoti RC. Shah NJ. Cirrhosis of liver simulating congenital cyanotic heart disease. Circulation 1966; 33: 71-77.

  43. Shijo H. Nakayama K. Sasaki H. Ueki T. Sakaguehi S. Sakata H. Reversibility of pulmonary telangiectasia in liver cirrhosis evidenced by serial dynamic pulmonary perfusion imaging. Clin Nucl Med 1989; 14: 909-11.

  44. Shijo M. Sasaki H, Sakata H. Kusuhara H. Ueki T. Okumura M. Reversibility of hepatopulmonary syndrome evidenced by serial pulmonary perfusion scan. Gastroenterol Jpn 1993; 2S: 126-31.

  45. Krowka MJ. Clinical Management of Hepatopulmonary Syndrome. Semin in Liver Dis. 1993; 13: 414-21.

  46. Abrams GA. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 1998; 27: 232-5.

  47. Selim KM. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol 1998; 93: 455-8.

  48. Corley DA, Scharschmidt B, BassN. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology 1997; 113: 1815-2025.

  49. Felt RW. Kozak BE. Rosch J. Hepatogenic pulmonary angiodysplasia treated with coil-spring embolization. Chest 1987; 91: 920-22.

  50. Rodriguez-Roisin R, Krowka MJ. Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach. Eur Respir J 1994; 7: 839-842.

  51. Schwarzenberg SJ, Freese D. Resolution of severe intrapulmonary shunting after liver transplantation. Chest 1993; 103: 1271-1273.

  52. Scott V, Miro A, Kang Y. Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation. Trans Proc 1993: 25: 1787-1788.

  53. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatolgy 1990,11: 138-142.

  54. Krowka MJ. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 1999; 5: 451-3.




2020     |     www.medigraphic.com